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Jørgen Jespersen, Kaare Christensen
Background—Inflammation variables (C-reactive protein [CRP], fibrinogen, and soluble intercellular adhesion molecule-1
[sICAM-1]) have been identified as risk factors for cardiovascular disease. It is still not known how much the regulation
of inflammatory risk factors is determined by genetic factors, and the aim of this study was to determine the heritability
of these inflammation variables and of the acute phase regulating cytokines interleukin-6 (IL-6) and tumor necrosis
factor- (TNF-) at older ages.
Methods and Results—The heritability of CRP, fibrinogen, sICAM-1, IL-6, and TNF- was determined in a twin study
consisting of 129 monozygotic twin pairs and 153 dizygotic same-sex twins aged 73 to 94 years who participated in the
Longitudinal Study of Aging of Danish Twins. Furthermore, we determined the influence of selected genetic
polymorphisms on the plasma level variations. Genetic factors accounted for 20% to 55% of the variation in plasma
levels of the inflammation variables. The highest heritability was found for sICAM-1. The genetic polymorphisms we
studied explained only a small, insignificant part of the heritability.
Conclusions—This study in elderly twins provides evidence for a substantial genetic component of inflammatory
cardiovascular risk factors among the elderly. (Arterioscler Thromb Vasc Biol. 2004;24:2168-2173.)
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Apositive family history of cardiovascular disease is astrong determinant of the risk of cardiovascular events
in epidemiological studies,1,2 and this observation was con-
firmed by a Swedish twin study in which death from coronary
heart disease showed a substantial genetic component.3
Within families, the genetic background and environmental
factors are shared, and twin studies are among the best studies
for disentangling the effects of genetic and environmental
components.
Inflammation is an important mechanism in cardiovascular
disease. The acute phase proteins C-reactive protein (CRP),4,5
fibrinogen,6 and soluble intercellular adhesion molecule-1
(sICAM-1)7 are consistently associated with the risk of
cardiovascular events in prospective population studies. The
levels of these inflammatory markers reflect the severity of
the underlying atherosclerosis in the vessel wall, but they may
also causally contribute to the development of cardiovascular
disease.8 As an example, CRP activates the classical pathway
of the complement system, functions as a scavenger factor,
and determines the uptake of low-density lipoprotein by
macrophages.9 Fibrinogen levels determine the rigidity and
fibrinolysis rate of clots; fibrinogen functions as a bridging
molecule for many types of cell–cell adhesion events and
provides a critical provisional matrix.10 ICAM-1 participates
in the adhesion of neutrophils and monocytes to the endothe-
lium, an essential step in extravasation of neutrophils and
monocytes at the site of inflammation.
The plasma levels of these variables show a large interin-
dividual and intraindividual variation.11 Inflammatory trig-
gers are the main determinants of the levels of these factors,
but also, genetic variations have been reported to explain part
of the variation in inflammatory variables. Studies of CRP12–15
and fibrinogen13,16–18 in healthy young and middle-aged twins
and in family studies suggest that a considerable part of the
variation in these factors can be explained by genetic factors.
Because cardiovascular disease is primarily a disease of the
elderly, it is important to assess how important genetic
variation in risk factors is in the elderly because they are
subject to many more triggers or risks than young individuals.
It may be expected that genetic factors make a different
contribution to the variation in the elderly compared with the
younger age groups. On one hand, it is possible that func-
tional genetic variations in the promoter region of the genes,
which determine response to triggers, contribute more in the
elderly because there are more triggers. On the other hand, the
surplus and variety of triggers present in later age may also
decrease the importance of genetic variation. Thus, it is not
clear whether a larger or smaller contribution of genetic
variation is expected, and evolution predicts the first, and
traditional gerontology predicts the latter.
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In addition to functional variations in genes of inflamma-
tion variables, functional genetic variations in factors that
regulate these variables may contribute to the variation in
plasma levels of inflammatory variables. Interleukin-6 (IL-
6)19 and tumor necrosis factor- (TNF-)20 are 2 important
regulatory cytokines for acute phase proteins21,22 that both
have a genetic contribution to their levels23 and that both have
functional genetic polymorphisms in their promoter region
that have been associated with their plasma levels.24,25 These
functional polymorphisms, for which an association with
levels has been shown repeatedly and is biologically plausi-
ble, are the most likely genetic variants to explain part of the
hereditary component that determines the plasma levels of the
inflammatory variables.
The aim of this study was to assess the overall genetic role
in variations of inflammation variables among the elderly.
Therefore, we determined the genetic contribution to the
variations in CRP, fibrinogen, sICAM-1 and the acute phase-
regulating cytokines IL-6 and TNF- in elderly twins (73 to
94 years old).
Subjects and Methods
Participants
A total of 584 individuals (190 males and 394 females) aged 73 to 94
years participated in this study. These individuals made up 129 intact
monozygotic (MZ) twin pairs and 153 intact dizygotic (DZ) same-
sex twin pairs. The twin pairs were identified using the Danish Twin
Registry and participated in the 1997 Longitudinal Study of Aging of
Danish Twins.26 The aim was to include a random sample of twins
so all twins who were able to finalize the interview and give
informed consent were eligible for participation in the study.
The Danish Twin Registry, a nationwide and population-based
registry established in 1954, comprises twins born between 1870 and
1930, surviving to the age of 6 years.26 Only same-sex twin pairs
were included in the present study. Zygosity was established through
a questionnaire on the degree of similarity between twins in a pair.
Zygosity classification was evaluated by comparison with blood
group determinants, and the misclassification rate was 5%.27
Methods
Blood samples (20 mL of EDTA blood) were collected within a
6-month period. The samples were centrifuged within 12 hours after
sampling at 1000g for 10 minutes, and plasma was frozen in aliquots
at 80°C within 2 days (usually within the same day). Plasma
samples were rapidly thawed in a water bath at 37°C. The protein
concentration of CRP was measured using a high-sensitivity in-
house enzyme immunoassay using rabbit anti-human CRP IgG as
capture and tagging antibody (DAKO). Human CRP Standard (Dade
Behring) was used as a calibrator. Protein concentrations of IL-6,
TNF-, and sICAM-1 were determined using high-sensitivity human
ELISAs (R&D Systems). The protein concentration of fibrinogen
was determined using a nephelometric method (Dade Behring).
Interassay coefficients of variation for the assays we used were: for
fibrinogen, 5.0%; IL-6, 10.1%; ICAM, 5.6%; TNF, 14.5%;
CRP, 6.5% based on 17 determinations from a single normal
plasma sample on different days.
Genomic DNA samples were analyzed using polymerase chain
reaction (PCR)-based methods. The fibrinogen -455G/A promoter
polymorphism was analyzed as described by Thomas et al.28 The
CRP-1059G/C polymorphism was analyzed as described by Zee et
al.29 The ICAM-1 K/E469 polymorphism was analyzed as described
by Nishimura et al.30 The IL-6–174C/T promoter polymorphism was
analyzed as described by Fishman et al.24 The TNF-–238G/A
promoter polymorphism was analyzed as described by Wennberg et
al.31 The genotype was determined in all individuals and monozy-
gosity was confirmed. In each PCR run, samples with known
genotypes were included. We also reanalyzed 10% of the samples (at
random), and the results were confirmed.
Analyses of Twin Similarity
The similarity in MZ and DZ twins was assessed using intraclass
correlations for inflammatory variables. The classic twin study
methodology is based on the fact that MZ twins have identical
genotypes, whereas DZ twins share, on average, half of their genes
and are no more genetically related than ordinary siblings. A greater
phenotypic similarity in MZ twins is to be expected if there is a
significant genetic component in the etiology of the component.
Analyses were adjusted (by linear regression) for age, sex, and body
mass index (BMI). To approximate a bivariate normal distribution,
data were transformed to the logarithmic scale, and probit plots
showed that the marginal distributions could be assumed to be
normal. Plasma levels of CRP 10 mg/L and levels of IL-6 10
pg/mL (6% of the individuals) are considered to reflect “clinical
inflammation”; these data and the data from the cotwin were
removed from the data set.
Estimation of Heritability
Heritability of the 5 traits, effects of covariates on traits and the
degree of dependence between the traits, were determined using
multivariate variance components models.32 Phenotypic (co)vari-
ances are decomposed into genetic and environmental components
by the Cholesky decomposition method. According to standard
biometric practice, assuming no epistasis (genetic inter locus inter-
action), no gene–environment interaction or correlation, and no
assortative mating, the phenotypic variance can be separated into 4
variance components: (A) variance attributable to additive genetic
effects; (D) genetic dominance; (C) shared (family) environment;
and (E) nonshared (individual-specific) environment.32 Only non-
shared environments contribute to dissimilarity within MZ twin pairs
because of their genetic identity, whereas the effects of additive
genetic factors and genetic dominance may also contribute to
dissimilarity within DZ pairs, who share, on average, half of the
additive and one-quarter of the dominant genetic factors. For each trait, the
heritability is the ratio of genetic variance to the total variance. Effects of the
covariates of each trait are given by the regression coefficients coming from
the covariate that is linearly added to the model (which corresponds to linear
regression of the covariates on traits and subsequent heritability analysis of
residuals thereof.
The multivariate model incorporates the 5 traits and associated
covariates and allows estimating the degree of dependence between
the traits (ie, correlations between the traits). Furthermore, the extent
to which the same genetic factors contribute to the observed
phenotypic correlation (ie, the degree of pleiotropy of possible genes
influencing the traits) is obtained from the model by estimating the
genetic correlations. The method for selecting the best model
followed standard procedures (structural-equation analyses) using
the Mx statistical program.32,33
Association Between Genotype and Phenotype
Association between the 5 polymorphisms and 5 trait levels in the
whole population was initially assessed by 1-way ANOVA (with
robust estimation of variance of phenotypes for individual twins
clustered into twin pairs because of possible within-pair depen-
dence). Sib-pair–based association analysis was performed using the
variance components models of association implemented in the
Quantitative Transmission Disequilibrium Test (QTDT) program,34
and in all analyses, gender, age, and BMI were included as
covariates. We tested for association in QTDT using the model by
Fulker et al,35 allowing for the effects of polygenes, shared family
environment, nonshared environment, and effect of linkage at the
locus under study. This model allows for the partitioning of observed
association into between-pair and within-pair components, thus
providing a check on whether results could have arisen because of
unsuspected population stratification among the pairs studied. Sub-
sequent permutation tests36 of association, which do not rely on the
bivariate normal distribution assumption, were performed using the
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QTDT program. Secondly, the amount of variation in the plasma
levels of the inflammatory variables attributable to the inflammatory
polymorphisms was studied using parametric linkage analysis im-
plemented in the Merlin program.36 There is no adjustment of the
mean levels for zygosity. It is an assumption that MZ and DZ pairs
come from the same population. There is no sign of violation of this
assumption (Table 1).
Allele frequencies were determined by gene counting, and 95%
CIs of the allele frequencies were calculated from sample allele
frequencies. Deviations of the genotype distributions from that
expected for a population in Hardy–Weinberg equilibrium were
analyzed using the  2 test.
Results
Table 1 shows the general characteristics of our elderly twin
population and the concentrations of inflammation variables
in the MZ and DZ twins. All characteristics are comparable in
the MZ and DZ twins. Concentrations of the inflammatory
variables are comparable in MZ and DZ twins.
The model chosen to explain the factors contributing to the
variance in the inflammatory cardiovascular risk factors is the
model including additive genetic effects, common environ-
mental effects, and nonshared environmental effects (ACE).
In all the traits, the common environmental effects were small
and nonsignificant (data not shown). The ACE model was
then used to estimate the heritability coefficients, effects of
covariates, and dependencies among the traits (ie, mutual
correlation of the traits and genetic correlation of the traits).
As covariates in our multivariate variance components
model, we included gender, age, and BMI. Plasma concen-
trations of IL-6 and TNF- increase with age, and the plasma
concentration of IL-6 decreases with increasing BMI,
whereas levels of CRP and fibrinogen increase with increas-
ing BMI (Table 2). We observed no significant gender effect
for any of the traits (Table 2).
The intraclass correlations in MZ twins were consistently
higher than those in DZ twins for all variables (Table 2). The
difference was statistically significant for ICAM-1
(P0.001). Heritability estimates, when adjusting for effects
of gender, age, and BMI, and when allowing for possible
dependencies between the traits, varied between 0.17 for IL-6
and 0.55 for sICAM-1 (Table 2). Mutual correlations between
the traits are given in Table 3. Between the plasma levels we
observed, as expected, significantly positive correlations
ranged from 0.17 to 0.55, indicating substantial relationship
among the traits. Significant genetic correlations, ranging
between 0.27 and 0.41, were seen between the cytokines and
CRP, fibrinogen, and sICAM-1, indicating a substantial
degree of pleiotropy (ie, a gene affecting 2 or more traits
[Table 3]). Small (and not significant) genetic correlations
were observed among CRP, fibrinogen, and sICAM-1, which
may indicate that the common genetic contribution to their
regulation is insignificant.
Polymorphisms in the inflammatory genes (-455G/A in
fibrinogen-, -1059G/C in CRP, K/E469 in ICAM-1,
-174C/T in IL-6, and -238G/A in TNF-) were all in
Hardy–Weinberg equilibrium, and the frequencies of the
alleles (Table 4) were comparable to those reported in other
white populations.25,37–40
When we studied the effect of polymorphisms in factors
upstream in the regulatory pathway of the cytokines and acute
phase proteins, evidence for an association between genotype
at the TNF–238G/A polymorphism and IL-6 was found by
ANOVA (P0.02; Table 5). This association was confirmed
using the sib-pair–based analysis (QTDT, 25.7 [1 df];
P0.02) performed using the genetic model by Fulker et al,35
which takes possible population stratification into account.
Associations were also seen for TNF–238G/A polymorphism
with CRP levels (P0.03) and for the fibrinogen–455G/A
polymorphism with fibrinogen levels (P0.03) by ANOVA,
TABLE 1. General Characteristics and Concentrations of
Inflammation Variables in MZ and DZ Elderly Twins
MZ Twins DZ Twins
Age (years) 78.1 (0.26) 77.9 (0.24)
Gender (intact pairs men/women) 44/88 51/109
BMI (kg/m2) 24.4 (0.23) 24.2 (0.23)
Current smokers 65 (25%) 92 (30%)
CRP (mg/L)§ 1.88 (1.64, 2.15) 2.05 (1.80, 2.32)
Fibrinogen (mol/L)§ 12.8 (12.4, 13.2) 12.9 (12.5, 13.2)
sICAM-1 (pg/mL)§ 286 (278, 294) 276 (270, 283)
IL-6 (pg/mL)§ 2.64 (2.46, 2.85) 2.68 (2.51, 2.86)
TNF- (pg/mL)§ 2.44 (2.35, 2.54) 2.54 (2.44, 2.65)
Values are mean (SE) or §geometric mean (95% CI). The SE is estimated,
correcting for the correlation within twin pairs.
TABLE 2. Heritability Estimates for Inflammatory Cardiovascular Risk Factors
CRP Fibrinogen sICAM1 IL-6 TNF-
n pairs (MZ/DZ) (112/129) (129/153) (129/153) (118/130) (126/151)
Age 0.0147 0.0026 0.0027 0.0204* 0.0160*
Sex 1.0911 0.1727 0.0192 0.5337 0.0547
BMI 0.0432* 0.0069* 0.0092 0.0957* 0.0618
ICC MZ 0.30 (0.25, 0.30) 0.30 (0.19, 0.41) 0.59 (0.48, 0.67) 0.27 (0.15, 0.38) 0.35 (0.21, 0.48)
ICC DZ 0.20 (0.19, 0.21) 0.19 (0.16, 0.28) 0.31 (0.24, 0.40) 0.18 (0.10, 0.23) 0.21 (0.14, 0.32)
Heritability 0.20 (0.16, 0.34) 0.21 (0.07, 0.25) 0.55 (0.34, 0.65) 0.17 (0.12, 0.28) 0.26 (0.01, 0.34)
Heritability estimates (95% CI) when assuming the multivariate model including additive genetic effects, common environmental
effects, and nonshared environmental effects (ACE).
The model allows adjustment (by linear regression) of covariate gender, age, and BMI.
Effects of covariates (*P0.05) and estimates of the intraclass correlations (ICC, 95% CI) for MZ and DZ pairs are shown.
Inferences are estimated under bivariate normality assumption.
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but these associations were not confirmed in the subsequent
sib-pair–based analysis.
No evidence for linkage between the polymorphisms and
the plasma levels of the inflammation variables was observed,
not even between the TNF- polymorphism and IL-6 levels.
However, power is limited for linkage studies in our cohort.
Discussion
This study describes that there is a clear genetic component in
levels of inflammatory cardiovascular risk factors in the
elderly. Selected functional polymorphisms in the genes of
fibrinogen-, CRP, ICAM-1, IL-6, and TNF- only ex-
plained a very small part of this variation.
The contribution of genetic variation to plasma levels of
fibrinogen in the elderly twins in our study was comparable
or somewhat smaller than the genetic contributions published
for younger, mostly middle-aged twins. For fibrinogen, the
additive genetic variance in our elderly twins (0.21) was
lower than the estimates determined in other twin studies,
which varied from 0.28 to 0.44.13,16,18 Family studies reported
heritabilities for fibrinogen between 0.20 and 0.51,16,41 and in
the Kibbutzim Family Study, it was observed that the herita-
bility decreased from 0.48 in 20-year-old individuals to 0.20
in 80-year-old individuals.42 It was expected that the effect of
genetic factors could be smaller in the elderly twins because
of the presence of many inflammatory triggers, such as
cardiovascular disease and other age-associated diseases. The
results of our study support this hypothesis, but it remains
unclear how much of the difference in heritability can be
attributed to age versus other population characteristics.
Only a small, insignificant part of this variance could be
explained by the -455G/A polymorphism in the promoter
region of the fibrinogen- gene, in accordance with other
reports.43 Polymorphisms in2000 bp of the promoter region
of the fibrinogen- gene were identified, and in whites, these
are in very strong linkage disequilibrium.44 Furthermore, we
recently found using luciferase expression studies that the
-148C/T polymorphism (which is in perfect linkage disequi-
librium with the -455G/A polymorphism in white popula-
tions) is the functional polymorphism in the promoter region,
explaining all promoter activity.45 Therefore, it is not ex-
pected that any new information will become available when
other polymorphisms are studied in this region. Also poly-
morphisms in the promoter region of IL-6 and TNF-, 2
major determinants of fibrinogen synthesis, explained only an
insignificant part of the variance in fibrinogen levels.
The genetic contribution to variation in the CRP concen-
tration appears somewhat lower in our study than in middle-
aged twins, for whom a clear genetic contribution has been
reported in a UK study (intraclass correlation coefficient of
0.57 in MZ twins and 0.31 in DZ twins)12 and in healthy
family studies.14,15 Polymorphisms in the promoter region of
CRP, IL-6, or TNF- did not explain a major part of this
genetic variance in our elderly twins, in contrast to the
observation of Vickers et al that the IL-6–174C/T poly-
morphism explains 14% of the CRP concentration.14 For
sICAM-1, no information was published on the heritability of
the levels, but the high estimate in our study makes this an
interesting candidate gene for further studies. For IL-6, the
heritability estimate in our study (0.17) is similar to an
estimate of heritability that is available from a family study
(0.24).23 For TNF-, the heritability estimate in our study
(0.26) was much lower than the estimates derived from
family studies (0.68 and0.80).23,46 The heritability of the in
vitro production of TNF- in a whole-blood stimulation
experiment was 0.60,47 which is also higher than the herita-
bility we saw in vivo in elderly twins. This suggests that the
responsiveness may have a stronger genetic component than
the baseline levels.
The hypothesis that responsiveness may be genetically
determined suggests that functional polymorphisms in the
regulatory elements of inflammatory genes may be determi-
nants of the plasma levels of inflammatory variables. How-
ever, the regulatory polymorphisms we studied in the genes
for fibrinogen, IL-6, CRP, and TNF- did not explain much
of the variance in their gene products, nor did polymorphisms
TABLE 3. Correlations Between Cytokines and Acute
Phase Proteins
CRP Fibrinogen ICAM-1 IL-6 TNF-
CRP (mg/L) 0.52* 0.22* 0.55* 0.22*
Fibrinogen (g/L) 0.13 0.19* 0.42* 0.17*
ICAM-1 (ng/mL) 0.23 0.09 0.24* 0.31*
IL-6 (ng/mL) 0.71# 0.60# 0.27* 0.23*
TNF- (ng/mL) 0.36* 0.41* 0.33* 0.21
The multivariate model allows for estimation of correlations between
cytokines and acute phase proteins. These correlations are given above the
diagonal. Furthermore, genetic correlations between cytokines and acute phase
proteins are given below the diagonal.
*P0.05; #P value could not be calculated.
TABLE 4. Frequencies of Polymorphisms in
Inflammation Genes
Polymorphism Genotype n
1059G/C in CRP GG 418
GC 48
CC 0
f(C) 0.05 (0.04, 0.07)
455G/A in fibrinogen- GG 299
GA 154
AA 16
f(A) 0.20 (0.17, 0.23)
K/E469 in ICAM-1 KK 162
KE 217
EE 90
f(E) 0.42 (0.39, 0.46)
174C/T in IL-6 CC 142
CT 227
TT 100
f(T) 0.46 (0.42, 0.49)
238G/A in TNF- GG 321
GA 124
AA 21
f(A) 0.18 (0.15, 0.21)
Given are frequencies of the rare alleles with the 95% CI.
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in the IL-6 and TNF- genes explain the variance in the levels
of the acute phase proteins. We studied polymorphisms for
which an association with levels has been shown repeatedly
and is biologically plausible. In addition to the fibrinogen
promoter, also for the other factors, the gene and a reasonable
part of the promoter region (on average up to 2000 bp) were
studied for functional polymorphisms, and we selected poly-
morphisms for which it was most likely that they would explain
a considerable part of the heritability.24,45,48 However, we cannot
exclude that other genetic variants have a major impact on the
plasma levels of these factors, and studies using full haplotype
analysis will be able to give a better estimation of the contribu-
tion of genetic variation in a gene to its plasma levels.
We only saw 1 possible association, but no linkage, for any
combination of polymorphism and plasma level, indicating
that twin pairs that share their alleles are not necessarily close
in trait values. This suggests that we did not study the
functional polymorphism or that a combination of poly-
morphisms affects the plasma level. The intriguing question
is what the genetic components are if they are not genetic
variants in the genes, variations in the promoter regions, or in
the regulating cytokine genes. The explanation for the high
heritability may therefore be found in enhancer elements
further away from the gene or in other genes that determine
the regulation of inflammatory factors, such as nuclear
proteins. The high genetic correlation between inflammatory
variables in our study may indicate a common genetic
regulatory mechanism.
BMI has a large genetic component and is also a major
determinant of inflammation variables, for example, by in-
creasing the cytokine production by adipose tissue.49 Further-
more, it is possible that the sensitivity of inflammatory
variables to BMI is genetically determined. Adjustment for
BMI in the statistical analysis may remove such a relation-
ship. Therefore, we analyzed the data unadjusted and adjusted
for BMI and noticed that the adjustment had no significant
effect on the heritability estimated in our population. This
suggests that different gene pools determine the inflammatory
variables and the BMI.
When studying the elderly, it cannot be excluded that there
has been a selection of our study population because only
individuals that survived to be 73 years old were included in the
study. However, that is a problem inherent in all aging research,
and the present study benefited from a high response rate (79%).
The calculated heritability may be an underestimate of the
underlying heritability because the procedure for processing
blood was not optimal, which may have given a spuriously
greater variation in the levels of the inflammatory markers.
Furthermore, the phenotypes show a great day-to-day varia-
tion because the inflammatory variables are very sensitive to
environmental factors.
In conclusion, levels of inflammatory cardiovascular risk
predictors are, to a large extent, genetically determined, even
in elderly individuals, and therefore, it is important to
elucidate the genetic factors involved in the regulation of
these proteins, especially in cardiovascular disease.
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TABLE 5. Relationship Between Polymorphisms and Plasma Protein Concentrations
Polymorphism Genotype CRP (mg/L) Fibrinogen (mol/L) ICAM (ng/mL) IL-6 (pg/mL) TNF- (pg/mL)
1059G/C in CRP GG 1.66 (0.28, 9.99)
GC 1.83 (0.30, 11.10)
CC –
P value NS
455G/A in fibrinogen- GG 12.55 (7.69, 20.49)
GA 13.46 (8.41, 21.55)
AA 13.07 (7.70, 22.18)
P value 0.02
K/E469 in ICAM-1 KK 278 (181, 428)
KE 278 (184, 420)
EE 290 (184, 455)
P value NS
174C/T in IL-6 CC 1.53 (0.29, 8.09) 12.55 (7.84, 20.09) 276 (184, 414) 2.56 (0.76, 8.67) 2.48 (1.11, 5.55)
CT 1.65 (0.27, 10.00) 12.81 (7.85, 20.91) 284 (177, 457) 2.64 (0.88, 7.96) 2.48 (1.28, 4.84)
TT 1.91 (0.29, 12.83) 13.20 (7.93, 21.97) 279 (197, 395) 2.81 (0.95, 8.27) 2.51 (1.37, 4.61)
P value NS NS NS NS NS
238G/A in TNF- GG 1.79 (0.29, 11.07) 12.94 (7.92, 21.12) 281 (183, 433) 2.69 (0.85, 8.50) 2.50 (1.28, 4.90)
GA 1.51 (0.29, 7.72) 12.81 (7.85, 20.91) 281 (179, 442) 2.69 (0.92, 7.87) 2.55 (1.22, 5.32)
AA 1.09 (0.16, 7.61) 11.82 (7.99, 17.50) 265 (169, 416) 1.91 (0.65, 5.63) 2.13 (1.09, 4.16)
P value 0.03 NS NS 0.02 0.05
Presented are the correlations between polymorphisms and plasma levels of the gene product and of proteins for which they are in the regulatory pathway.
Geometric mean and 95% CIs are given for the plasma levels.
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